Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | (S)-4-Benzyl-3-((2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-yl}-propionyl)-oxazolidin-2-one | HCID 11444748 | — |
| Product | Aleglitazar | HCID 10274777 | — |
Reaction Steps
0.195 g of the above prepared (S)-4-benzyl-3-((2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-yl}-propionyl)-oxazolidin-2-one (0.32 mmol) was dissolved in 2.25 ml of THF and treated with 0.81 ml of 1N NaOH (2.5 eq.). The reaction mixture was kept at 0° and progress of the hydrolysis followed by TLC. After 1 h the reaction mixture was quenched by pouring onto crashed ice/HCl. Twofold extraction with AcOEt, washing with water and brine, drying over magnesium sulfate, and evaporation of the solvents left a crude product, which was purified by twofold crystallisation from AcOEt/hexane to remove the chiral auxiliary. Thereby, 0.102 g of the title compound was obtained as white solid, mp.118-120°. The enantiomeric excess was judged according to 1H-NMR in the presence of a large excess of optically pure trifluoromethyl-anthryl-ethanol to be >95%. According to chiral HPLC (Chiralpak-AD) it amounts to 99.3%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06642389B2 |
|---|
| Source dataset | uspto-grants-2003_11 |
|---|
| ORD ID | ord-2ed97b20915840d9acde9731811a5f31 |
|---|
| Source note | uspto-grants-2003_11 |
|---|